Skip to main content

D. E. Shaw & Co., Inc.

Position in RXST — RxSight, Inc.

CIK 1009207 New York, NY

Position in RXST

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$12,071,949
-$7,557,548 QoQ
Shares Held
1,959,732
+4.0% QoQ
Ownership
4.73%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Jun 2023
12 quarters on record
Voting authority Sole 99% Shared 0% None 1%

Common Shares in RXST Over Time

Shares Held

Position Value (USD)

Derivatives in RXST

reported options exposure · as of Sep 30, 2024
CallValue
$0
CallShares
0
PutValue
$266,922
PutShares
5,400

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Medical Devices

Healthcare · as of Mar 31, 2026

D. E. Shaw & Co., Inc. holds $2,885,787,974 across 58 Medical Devices names. RXST ranks #17 (0.4% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in RXST

Export CSV
14 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $12,071,949 1,959,732
2025-12-31 $19,629,497 1,883,829
2025-09-30 $16,486,679 1,833,891
2025-06-30 $17,177,290 1,321,330
2025-03-31 $555,500 22,000
2024-12-31 $329,016 9,570
2024-09-30 $266,922 5,400
2024-09-30 $5,061,187 102,391
2024-06-30 $16,537,002 274,838
2024-06-30 $463,309 7,700
2024-03-31 $17,690,908 342,980
2023-12-31 $8,006,342 198,570
2023-09-30 $2,462,324 88,287
2023-06-30 $3,902,284 135,496